OptimizeRx OPRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.4M— | —— | —— | —— | $3.25M— | ||
| $4.73M— | —— | —— | —— | $4.99M— | ||
| $19.45M— | —— | —— | —— | $24.03M— | ||
| -$495K-110% | $5.02M+544% | $779K-49.2% | $1.53M+170% | -$2.2M-2,719% | ||
| $1.46M-84.9% | $9.65M+208% | $3.13M-26.6% | $4.26M+523% | -$1.01M— | ||
| $396K-95.4% | $8.57M+318% | $2.05M-35.7% | $3.19M+252% | -$2.1M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is OptimizeRx's revenue?
- OptimizeRx (OPRX) generated $107.3M in revenue over the trailing twelve months, up 39.8% year over year.
- Is OptimizeRx profitable?
- OptimizeRx reported $6.8M in net income over the trailing twelve months, a 6.4% net margin.
- What are OptimizeRx's profit margins?
- Gross margin is 70.0% and operating margin is 13.2%, with a 6.4% net margin.
- What is OptimizeRx's earnings per share?
- OptimizeRx's diluted EPS over the trailing twelve months is $0.35.
- Where does OptimizeRx's income statement data come from?
- Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
